Clinical Trial Update: Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study investigating the effect of L-ornithine-L-aspartate (LOLA) on the gut microbiome in patients with cirrhosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• LOLA (L-ornithine-L-aspartate) (L-ornithine-L-aspartate)

Snippet

Sponsor: Medical University of Graz | Conditions: Cirrhosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING